Literature DB >> 20608611

Anatomic and visual outcomes of vitrectomy for vitreomacular traction syndrome.

Andre J Witkin1, Mark E Patron, Leonardo C Castro, Elias Reichel, Adam H Rogers, Caroline R Baumal, Jay S Duker.   

Abstract

BACKGROUND AND
OBJECTIVE: To assess anatomic and visual outcomes after pars plana vitrectomy for vitreomacular traction syndrome. PATIENTS AND METHODS: Charts of 746 patients who had vitrectomy surgery with membrane peel between January 2002 and December 2007 were reviewed. Vitreomacular traction syndrome (VMT) was diagnosed based on optical coherence tomography (OCT) appearance. Twenty eyes of 20 patients were found to have had vitrectomy surgery for VMT and were included in the study.
RESULTS: Mean visual acuity was 20/122 preoperatively and 20/68 postoperatively (P = .005). Mean foveal thickness was 404.00 microm preoperatively and 250.55 microm postoperatively (P = .001). A subgroup analysis was performed based on preoperative OCT appearance. Improvement in vision was not significant in eyes with lamellar separation between the inner and outer fovea (P = .379), but was significant in eyes with cystoid macular edema (P = .045) or perifoveal traction (P = .040).
CONCLUSION: Overall, there was a significant improvement in visual acuity and central foveal thickness postoperatively. Eyes with lamellar separation of the inner and outer foveal layers preoperatively had worse visual results, whereas eyes with cystoid macular edema or perifoveal VMT had better visual results.

Entities:  

Mesh:

Year:  2010        PMID: 20608611     DOI: 10.3928/15428877-20100525-07

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  10 in total

1.  The Charles Schepens Lecture: Management Options for Vitreomacular Traction: Use an Individualized Approach.

Authors:  Harry W Flynn; Nidhi Relhan
Journal:  Ophthalmol Retina       Date:  2017 Jan-Feb

2.  Pneumatic release of focal vitreomacular traction.

Authors:  M G Claus; E Feron; M Veckeneer
Journal:  Eye (Lond)       Date:  2016-11-04       Impact factor: 3.775

3.  Clinical outcomes of double membrane peeling with or without simultaneous phacoemulsification/gas tamponade for vitreoretinal-interface-associated (VRI) disorders.

Authors:  Kshitiz Kumar; Nisha Chandnani; Pallavi Raj; Amar Agarwal
Journal:  Int Ophthalmol       Date:  2015-12-12       Impact factor: 2.031

4.  Vitreomacular traction syndrome.

Authors:  Juliana Bottós; Javier Elizalde; J Fernando Arevalo; Eduardo B Rodrigues; Maurício Maia
Journal:  J Ophthalmic Vis Res       Date:  2012-04

Review 5.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17

6.  Effect of pneumatic vitreolysis in management of patients with symptomatic focal vitreomacular traction.

Authors:  Ahmed N Fouad; Iman M Eissa; Ghada A Nassar; Mahmoud Leila; Adel M Fathy
Journal:  Int J Retina Vitreous       Date:  2022-03-28

Review 7.  Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment.

Authors:  D H W Steel; A J Lotery
Journal:  Eye (Lond)       Date:  2013-10       Impact factor: 3.775

8.  Surgical therapy versus observation for lamellar macular hole: a retrospective comparison study.

Authors:  Huseyin Sanisoglu; Ahmet Elbay; Sahin Sevim; Ugur Celik; Fatma B Aktas; Ebubekir Durmus
Journal:  Clin Ophthalmol       Date:  2013-09-18

Review 9.  Redesigning services for the management of vitreomacular traction and macular hole.

Authors:  W Amoaku; P Cackett; A Tyagi; U Mahmood; J Nosek; G Mennie; N Rumney
Journal:  Eye (Lond)       Date:  2014-07       Impact factor: 3.775

10.  Indications and outcomes for intravitreal injection of C3F8 gas for symptomatic vitreomacular traction.

Authors:  Josef Guber; Celine Rusch; Ivo Guber; Hendrik P N Scholl; Christophe Valmaggia
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.